ShannonShung-LingChangMD
Gastroenterology • New York, NYAssociate Professor of Medicine, Inflammatory Bowel Disease Center
Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
305 East 33rd Street
New York, NY 10016
Education & Training
NYU Grossman School of MedicineFellowship, Gastroenterology, 2013 - 2016
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2010 - 2013
Tulane University School of MedicineClass of 2010
Certifications & Licensure
FL State Medical License 2022 - 2026
NY State Medical License 2011 - 2026
CT State Medical License 2022 - 2025
NJ State Medical License 2022 - 2025
PA State Medical License 2022 - 2024
OH State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics Start of enrollment: 2015 Dec 03
- Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Start of enrollment: 2017 Feb 03
- Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease Start of enrollment: 2017 Sep 29
Publications & Presentations
PubMed
- 1 citationsOral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease.Kush Fansiwala, Alison Rusher, Brandon Shore, Hans H Herfarth, Edward Barnes
Inflammatory Bowel Diseases. 2024-12-05 - 1 citationsRisankizumab Is Effective for The Management of Crohn's Disease of the Pouch.Maia Kayal, Elizabeth A Spencer, Matthew Smyth, Laura Raffals, Taha Qazi
Inflammatory Bowel Diseases. 2024-07-22 - Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry.Steven H Itzkowitz, Yue Jiang, Cristina Villagra, Jean-Frederic Colombel, Keith Sultan
Clinical Gastroenterology and Hepatology. 2024-05-18
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
- Making the Cut: An Isolated Filiform PolypShannon Chang, Mark Pochapin, Abraham Khan, Clinical Gastroenterology and Hepatology
Press Mentions
7 Crohn's Disease Symptoms Beyond Abdominal Pain, and How They May Affect YouApril 3rd, 2019
Inconvenient No More — Partnership Makes GI Guidelines Easier to UseDecember 4th, 2018
MDCalc Launches Beta GI Guideline Summaries with American College of GastroenterologyDecember 3rd, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
